Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AIM ImmunoTech Inc | AIM | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.012 | -2.67% | 0.438 | 0.4559 | 0.42 | 0.4559 | 0.45 | 19:59:41 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 421 | 204,007 | $ 0.4444927 | $ 90,680 | 253,844 | 0.42 - 3.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:41 | 6,780 | $ 0.438 | USD |
AIM ImmunoTech Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.12M | 4.84M | $ 2.52M | -9.86 | - | 1.89M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 51.45k | $ - | 0.00% | - | - |
AIM ImmunoTech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.515 | 0.52 | 0.42 | 0.4665778 | 218,948 | -0.077 | -14.95% |
| 1 Month | 0.5625 | 0.5857 | 0.42 | 0.4991666 | 203,357 | -0.1245 | -22.13% |
| 3 Months | 1.96 | 3.88 | 0.42 | 1.29 | 615,805 | -1.52 | -77.65% |
| 6 Months | 1.96 | 3.88 | 0.42 | 1.29 | 615,805 | -1.52 | -77.65% |
| 1 Year | 1.96 | 3.88 | 0.42 | 1.29 | 615,805 | -1.52 | -77.65% |
| 3 Years | 1.96 | 3.88 | 0.42 | 1.29 | 615,805 | -1.52 | -77.65% |
| 5 Years | 1.96 | 3.88 | 0.42 | 1.29 | 615,805 | -1.52 | -77.65% |
AIM ImmunoTech Description
| AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States. |
